Long-Term Benefit of Empagliflozin on Life Expectancy in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular Disease

Primary Author

Claggett,Brian

Lachin,John M.

Hantel,Stefan

Fitchett,David

Inzucchi,Silvio E.

Woerle,Hans J.

George,Jyothis T.

Zinman,Bernard

Volume

138

Issue

15

Start Page

1599

Other Pages

1601

Reference Type

Journal Article

Periodical Full

Circulation (New York, N.Y.)

Publication Year

2018

Publication Date

Oct 9,

ISSN/ISBN

0009-7322

Document Object Index

10.1161/CIRCULATIONAHA.118.033810